Related Experiment Video
Updated: Dec 21, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Alex D Waldman1,2, Jill M Fritz1,2, Michael J Lenardo3,4
1Molecular Development of the Immune System Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
T lymphocytes are key to cancer immunotherapy, driving new treatments like checkpoint blockade and cellular therapy. Research highlights their regulation, clinical successes, and future potential in fighting cancer.
Area of Science:
- Immunology
- Oncology
- Cellular Biology
Background:
- T lymphocytes are crucial for anti-cancer immunity, particularly their cytotoxic functions.
- Advances in understanding T cell biology have spurred novel cancer immunotherapeutics.
- Immunological research in cancer has seen significant progress over 50 years, leading to clinical breakthroughs.
Purpose of the Study:
- To provide a historical and biological overview of cancer immunotherapeutics.
- To emphasize the role of T lymphocyte regulation in cancer treatment.
- To review clinical trial data on efficacy and toxicity of immunotherapies.
Main Methods:
- Literature review of historical and biological perspectives.
- Analysis of clinical trial outcomes for cancer immunotherapies.
- Synthesis of current research and future directions.
Main Results:
- T cell-mediated cytotoxicity is central to cancer immunotherapy development.
- Checkpoint blockade, adoptive cellular therapy, and cancer vaccinology are key strategies.
- Clinical trials demonstrate significant therapeutic efficacy and varying toxicities.
Conclusions:
- T lymphocyte regulation is fundamental to successful cancer immunotherapy.
- Emerging therapies hold promise for improved cancer treatment.
- Further research is needed to address remaining questions and optimize future strategies.
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Targeted Cancer Therapies
There are several types of targeted therapies against...

